$36.76
-0.25-0.68%
At close: -
$36.76
00.00%
After Hours: 4:56 PM EDT
15 minutes delayed
GSK reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GSK using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $1.29 | $1.23 | 4.88 % |
Jun 2024 | 2024-07-31 | $1.10 | $0.99 | 11.1 % |
Mar 2024 | 2024-05-01 | $1.09 | $0.91 | 20.1 % |
Dec 2023 | 2024-01-31 | $0.72 | $0.75 | -4.27 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $10.42B | $10.78B | -3.36 % |
Jun 2024 | 2024-07-31 | $9.95B | $9.70B | 2.55 % |
Mar 2024 | 2024-05-01 | $9.34B | $8.92B | 4.69 % |
Dec 2023 | 2024-01-31 | $10.07B | $9.61B | 4.73 % |
GSK (GSK) is scheduled to report earnings on January 29, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $1.29, which beat the estimate of $1.23.
The Actual Revenue was $10.4B, which missed the estimate of $10.8B.
Browse earnings estimates, EPS, and revenue on all stocks.